Skip to main content
SpringerLink
Log in

Postoperative autologous blood transfusion drain or no drain in primary total hip arthroplasty? A randomised controlled trial

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

Postoperative maintenance of high haemoglobin (Hb) levels and avoidance of homologous blood transfusions is important in total hip arthroplasty (THA). The introduction of a postoperative drainage autologous blood transfusion (ABT) system or no drainage following THA has resulted in reduction of homologous blood transfusion requirements compared with closed-suction drains. The purpose of this study was to examine which regimen is superior following THA.

Methods

A randomised controlled blinded prospective single-centre study was conducted in which 100 THA patients were randomly allocated to ABT or no drainage. The primary endpoint was the Hb level on the first postoperative day.

Results

The postoperative collected drained blood loss was 274 (±154) ml in the ABT group, of which 129 (±119) ml was retransfused (0–400). There was no statistical difference in Hb levels on the first postoperative day (ABT vs no drainage: Hb 11.0 vs 10.9 g/dl), on consecutive days (day 3: Hb 10.7 vs 10.2, p = 0.08) or in total blood loss (1,506 vs 1,633 ml), homologous transfusions, pain scores, Harris Hip Score, SF-36 scores, length of hospital stay or adverse events.

Conclusions

The use of a postoperative autologous blood retransfusion drain did not result in significantly higher postoperative Hb levels or in less total blood loss or fewer homologous blood transfusions compared with no drain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 86:561–565

    PubMed  CAS  Google Scholar 

  2. Husted H, Holm G, Jacobsen S (2008) Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: fast-track experience in 712 patients. Acta Orthop 79:168–173

    Article  PubMed  Google Scholar 

  3. Conlon NP, Bale EP, Herbison GP, McCarroll M (2008) Postoperative anemia and quality of life after primary hip arthroplasty in patients over 65 years old. Anesth Analg 106:1056–1061

    Article  PubMed  Google Scholar 

  4. Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF (2012) Postoperative anemia does not impede functional outcome and quality of life early after hip and knee arthroplasties. Transfusion 52:261–270

    Article  PubMed  CAS  Google Scholar 

  5. Saleh E, McClelland DB, Hay A, Semple D, Walsh TS (2007) Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 99:801–808

    Article  PubMed  CAS  Google Scholar 

  6. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81:2–10

    PubMed  CAS  Google Scholar 

  7. Blumberg N (1997) Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 34:34–40

    PubMed  CAS  Google Scholar 

  8. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W (2005) Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 45:103–110

    Article  PubMed  Google Scholar 

  9. Murphy P, Heal JM, Blumberg N (1991) Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 31:212–217

    Article  PubMed  CAS  Google Scholar 

  10. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA (2010) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 3:CD001888

    PubMed  Google Scholar 

  11. Zacharopoulos A, Apostolopoulos A, Kyriakidis A (2007) The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. Int Orthop 31:303–308

    Article  PubMed  CAS  Google Scholar 

  12. Sinha A, Sinha M, Burgert S (2001) Reinfusion of drained blood as an alternative to homologous blood transfusion after total knee replacement. Int Orthop 25:257–259

    Article  PubMed  CAS  Google Scholar 

  13. Strümper D, Weber EW, Gielen-Wijffels S, Van Drumpf R, Bulstra S, Slappendel R, Durieux ME, Marcus MA (2004) Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 44:1567–1571

    Article  PubMed  Google Scholar 

  14. Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P (2007) Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion 47:379–384

    Article  PubMed  Google Scholar 

  15. Parker MJ, Livingstone V, Clifton R, McKee A (2007) Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev 3:CD001825

    PubMed  Google Scholar 

  16. Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51:737–755

    PubMed  CAS  Google Scholar 

  17. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33:AS264–AS279

    Article  PubMed  Google Scholar 

  18. Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anesthesiology 58:277–280

    Article  PubMed  CAS  Google Scholar 

  19. The Dutch Institute for Healthcare Improvement (CBO) Allogenic Blood Transfusion Guideline, p 109. http://www.cbo.nl/Downloads/96/bloedrl2004.pdf

  20. Colwell CW Jr, Beutler E, West C, Hardwick ME, Morris BA (2002) Erythrocyte viability in blood salvaged during total joint arthroplasty with cement. J Bone Joint Surg Am 84-A:23–25

    PubMed  Google Scholar 

  21. Stachura A, Król R, Poplawski T, Michalik D, Pomianowski S, Jacobsson M, Aberg M, Bengtsson A (2011) Transfusion of intra-operative autologous whole blood: influence on complement activation and interleukin formation. Vox Sang 100:239–246

    Article  PubMed  CAS  Google Scholar 

  22. Elawad AA, Ohlin AK, Berntorp E, Nilsson IM, Fredin H (1991) Intraoperative autotransfusion in primary hip arthroplasty. A randomized comparison with homologous blood. Acta Orthop Scand 62:557–562

    Article  PubMed  CAS  Google Scholar 

  23. Gharehbaghian A, Haque KM, Truman C, Evans R, Morse R, Newman J, Bannister G, Rogers C, Bradley BA (2004) Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency. Lancet 363:1025–1030

    Article  PubMed  Google Scholar 

  24. Sinardi D, Marino A, Chillemi S, Irrera M, Labruto G, Mondello E (2005) Composition of the blood sampled from surgical drainage after joint arthroplasty: quality of return. Transfusion 45:202–207

    Article  PubMed  Google Scholar 

  25. Sparrow RL (2010) Red blood cell storage and transfusion-related immunomodulation. Blood Transfus 8(Suppl 3):s26–s30

    PubMed  Google Scholar 

  26. Johnson BA, Weil MH (1991) Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses. Crit Care Med 19:1432–1438

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Kennemer Gasthuis, Haarlem, The Netherlands

    Wieger G. Horstmann

  2. Isala Clinics, Zwolle, The Netherlands

    Bart M. Kuipers & Cees C. P. M. Verheyen

  3. Perioperative Medicine Consultancy, Nijmegen, The Netherlands

    Rob Slappendel

  4. University Medical Center Utrecht, Utrecht, The Netherlands

    Rene M. Castelein

  5. University Medical Center Groningen, Groningen, The Netherlands

    Boudewijn J. Kollen

Authors
  1. Wieger G. Horstmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bart M. Kuipers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rob Slappendel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rene M. Castelein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Boudewijn J. Kollen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cees C. P. M. Verheyen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wieger G. Horstmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horstmann, W.G., Kuipers, B.M., Slappendel, R. et al. Postoperative autologous blood transfusion drain or no drain in primary total hip arthroplasty? A randomised controlled trial. International Orthopaedics (SICOT) 36, 2033–2039 (2012). https://doi.org/10.1007/s00264-012-1613-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-012-1613-7

Keywords

Search

Navigation